Back to Results

A PHASE II STUDY TO EVALUATE THE SAFETY AND EFFICACY OF OQL011 ON VEGFR INHIBITOR-ASSOCIATED HAND-FOOT SKIN REACTION IN CANCER PATIENTS

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Supportive Care

Locations

Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Elaine Lam,  MD

Elaine Lam, MD

Study ID

Protocol Number: 19-2242

More information available at ClinicalTrials.gov: NCT04088318

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers